In vitro activity of Rezafungin (CD101) against Candida species
dc.contributor.advisor | Majoros, László | |
dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Orvosi Mikrobiológiai Intézet | hu_HU |
dc.contributor.author | Barabas, Kristina | |
dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
dc.contributor.opponent | Gesztelyi, Rudolf | |
dc.contributor.opponent | Barta, Zsolt | |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
dc.contributor.opponentdept | Debreceni Egyetem::Általános Orvostudományi Kar::Belgyógyászati Intézet | hu_HU |
dc.date.accessioned | 2021-05-16T06:42:26Z | |
dc.date.available | 2021-05-16T06:42:26Z | |
dc.date.created | 2021-03-08 | |
dc.description.abstract | The in vitro antifungal activity of rezafungin, a second-generation echinocandin, was compared to other commonly-used antifungals. The inhibitory activity of antifungals against common and rare Candida species was tested using broth microdilution method. Compared to caspofungin, anidulafungin, micafungin, amphotericin B and fluconazole, rezafungin showed excellent activity against common and rare Candida species. In particular, rezafungin showed promising activity against the emerging multidrug resistant pathogen Candida auris. | hu_HU |
dc.description.course | általános orvos | hu_HU |
dc.description.courselang | angol | hu_HU |
dc.description.degree | egységes, osztatlan | hu_HU |
dc.format.extent | 31 | hu_HU |
dc.identifier.uri | http://hdl.handle.net/2437/309650 | |
dc.language.iso | en | hu_HU |
dc.subject | Candida | hu_HU |
dc.subject | antifungal therapy | hu_HU |
dc.subject | rezafungin | hu_HU |
dc.subject.dspace | DEENK Témalista::Orvostudomány::Orvosi mikrobiológia | hu_HU |
dc.title | In vitro activity of Rezafungin (CD101) against Candida species | hu_HU |